A team of a dozen executives at drugmaker Gilead Sciences Inc. meets daily to discuss the coronavirus epidemic in China and the company’s cross-continental scramble to develop the first drug for the new disease. If the company’s drug succeeds in studies in China, it could become the first treatment proven to work against a respiratory virus...

Source: Wall Street Journal February 12, 2020 15:55 UTC